WO2006138647A3 - Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs - Google Patents

Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs Download PDF

Info

Publication number
WO2006138647A3
WO2006138647A3 PCT/US2006/023622 US2006023622W WO2006138647A3 WO 2006138647 A3 WO2006138647 A3 WO 2006138647A3 US 2006023622 W US2006023622 W US 2006023622W WO 2006138647 A3 WO2006138647 A3 WO 2006138647A3
Authority
WO
WIPO (PCT)
Prior art keywords
human antibodies
recombinant human
making recombinant
biosensor technology
biosensor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/023622
Other languages
English (en)
Other versions
WO2006138647A2 (fr
Inventor
Gregory Liposky
Byron V Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
rEVO Biologics Inc
Original Assignee
GTC Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/156,831 external-priority patent/US20060286548A1/en
Application filed by GTC Biotherapeutics Inc filed Critical GTC Biotherapeutics Inc
Publication of WO2006138647A2 publication Critical patent/WO2006138647A2/fr
Publication of WO2006138647A3 publication Critical patent/WO2006138647A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Selon cette invention, on utilise un appareil des procédés pour produire des anticorps modifiés et calins destiné à être utilisé dans des applications de biocapteurs.
PCT/US2006/023622 2005-06-16 2006-06-16 Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs Ceased WO2006138647A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/156,831 2005-06-16
US11/156,831 US20060286548A1 (en) 2005-06-16 2005-06-16 Method of making recombinant human antibodies for use in biosensor technology
PCT/US2005/021476 WO2007001264A2 (fr) 2005-06-16 2005-06-17 Procede pour produire des anticorps humain de recombinaison utilises dans le cadre d'une technologie de biocapteur
USPCT/US2005/021476 2005-06-17

Publications (2)

Publication Number Publication Date
WO2006138647A2 WO2006138647A2 (fr) 2006-12-28
WO2006138647A3 true WO2006138647A3 (fr) 2007-05-03

Family

ID=37571259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/023622 Ceased WO2006138647A2 (fr) 2005-06-16 2006-06-16 Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs

Country Status (1)

Country Link
WO (1) WO2006138647A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063810A1 (fr) * 1981-04-29 1982-11-03 Ciba-Geigy Ag Dispositif et trousses pour les analyses immunologiques
WO1997042835A1 (fr) * 1996-05-13 1997-11-20 Genzyme Transgenics Corporation Purification de peptides de lait, actifs du point de vue biologique
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US20020055125A1 (en) * 2000-06-05 2002-05-09 Chiron Corporation Microarrays for performing proteomic analyses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063810A1 (fr) * 1981-04-29 1982-11-03 Ciba-Geigy Ag Dispositif et trousses pour les analyses immunologiques
WO1997042835A1 (fr) * 1996-05-13 1997-11-20 Genzyme Transgenics Corporation Purification de peptides de lait, actifs du point de vue biologique
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US20020055125A1 (en) * 2000-06-05 2002-05-09 Chiron Corporation Microarrays for performing proteomic analyses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHANG T-W: "BINDING OF CELLS TO MATRICES OF DISTINCT ANTIBODIES COATED ON SOLID SURFACE", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER, AMSTERDAM, NL, vol. 65, no. 1-2, 1983, pages 217 - 223, XP009018805, ISSN: 0022-1759 *
GOLDMAN M: "Processing Challenges for Transgenic Milk Products", BIOPROCESS INTERNATIONAL, INFORMA LIFE SCIENCES GROUP, WESTBOROUGH, MA, US, vol. 1, October 2003 (2003-10-01), pages 60 - 63, XP009074885, ISSN: 1542-6319 *
SASAKURA Y ET AL: "PROTEIN MICROARRAY SYSTEM FOR DETECTING PROTEIN-PROTEIN INTERACTIONS USING AN ANTI-HIS-TAG ANTIBODY AND FLUORESCENCE SCANNING: EFFECTS OF THE HEME REDOX STATE ON PROTEIN-PROTEIN INTERACTIONS OF HEME-REGULATED PHOSPHODIESTERASE FROM ESCHERICHIA COLI", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 76, no. 22, 15 November 2004 (2004-11-15), pages 6521 - 6527, XP001225801, ISSN: 0003-2700 *

Also Published As

Publication number Publication date
WO2006138647A2 (fr) 2006-12-28

Similar Documents

Publication Publication Date Title
WO2007001264A3 (fr) Procede pour produire des anticorps humain de recombinaison utilises dans le cadre d'une technologie de biocapteur
SG10201600950TA (en) Recombinant monovalent antibodies and methods for production thereof
SI3219328T1 (sl) Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe
IL195191A0 (en) Fusion proteins, uses thereof and processes for producing same
WO2008085962A3 (fr) Méthodes de culture cellulaire destinées à la production de protéines recombinées en présence de niveaux réduits d'un ou plusieurs contaminants
WO2007070538A9 (fr) Anticorps anti-mn et leurs procedes d'utilisation
EP2102355A4 (fr) Protéines et peptides à action prolongée et procédés de production et d'utilisation de ces derniers
WO2010009879A3 (fr) Procédés de production de paricalcitol
WO2010136483A3 (fr) Protéines de liaison à l'antigène
EP1969127B8 (fr) Procédé de production de protéines dépendantes de la vitamine k biologiquement actives par des procédés recombinants
GB2458419B (en) Vector for expressing NC protein of HIV and method for producing NC protein using the same
WO2008127711A3 (fr) Interférons d'origine rhésus et cynomolgus et leurs utilisations
EP1932855A4 (fr) Complexe de lactoferrine et procédé de production de celui-ci
GB0400394D0 (en) Biosensor and method of manufacture
WO2010108182A3 (fr) Production de protéines de recombinaison dans des ciliés et leurs utilisations
WO2009061402A3 (fr) Procédés et composés pour un phototransfert
WO2009087173A3 (fr) Anticorps appelé barb3, anticorps apparentés à barb3, et leurs procédés de fabrication et d'utilisation
EP2099437A4 (fr) Construction kératinique poreuse et procédé de fabrication de celle-ci
EP2052627A4 (fr) Fromage fondu et procédé de fabrication
WO2006138647A3 (fr) Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs
GB0514728D0 (en) Biosensor and method of manufacture
WO2006013462A3 (fr) Facteurs de croissance nsg28, nsg30, et nsg32
WO2004078936A3 (fr) Procedes permettant d'empecher la glyconoylation de proteines
WO2006005621A3 (fr) Procede de fabrication de conjugues albumine/corticoides
ZA200804337B (en) Recombinant monovalent antibodies and methods for production thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06785041

Country of ref document: EP

Kind code of ref document: A2